Ontology highlight
ABSTRACT: Importance
Prostate-specific antigen (PSA) screening for prostate cancer has resulted in a slight reduction in prostate cancer mortality but also a concomitant overdiagnosis of low-risk tumors. Prostate-specific antigen levels are affected by use of cholesterol-lowering statin drugs, but the association of statin use with PSA screening performance is unknown.Objective
To investigate whether statin use was associated with outcomes of a randomized PSA-based prostate cancer screening intervention.Design, setting, and participants
This post hoc subgroup analysis of a cohort from a population-based randomized clinical trial used data from the population-based Finnish Randomized Study of Prostate Cancer Screening, which randomized men to PSA screening or routine care from
SUBMITTER: Vettenranta A
PROVIDER: S-EPMC8777566 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature